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ABSTRACT
Using data on all high- and medium-tech start-ups in the UK in 2000, this paper looks at
whether the decision to patent affects subsequent growth in total assets between 2001 and 2005.
Identifying any patent effect relies on specific assumptions concerning the timing and nature
of the patent decision. The low survival rate of firms, 40% fail before 2005, means we control
for sample selection. The findings suggest that patentees may have asset growth of between 6%
to 17% per annum higher that non-patentees. There is some evidence that EPO patents are
particularly beneficial to the smallest start-ups.
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1 Introduction
The question in the title can be interpreted in various ways. Perhaps the most straight-
forward interpretation is ‘do patents improve the growth, profitability or productivity
of patenting small firms when compared to firms that do not patent?’ The issue is
one of private, firm-level performance and comparing patentees with non-patentees.
The major difficulty in providing any information on this issue is one of data. First,
one must have data on the patenting of smaller firms. Obtaining such data normally
encounters a large sample selection problem: small data sets, surveys or case studies
often just look at successful firms and also those keen to report the success of their
patents. Second, one needs financial data on some performance measure, ideally after
the patent was filed, published or granted. Third, given the absence of the counterfac-
tual (i.e., what would a firm’s performance have been, had it not patented?) a good
test requires a comparison with a control group of non-patentees. This control group
needs to contain similar small firms; in other words small firms that are engaged in
invention and innovation but, for whatever reason, chose not to patent. Given the huge
heterogeneity of small firms, and also in the innovation process, finding a control group
is a difficult task. This is compounded by the fact that smaller firms report relatively
little data on their activities.
The above reasons account for why there are very few research papers in this area.1
Nevertheless, policymakers are very interested in the issue of small firms and patent-
ing (Gowers, 2006). The patent system aims to give inventors and small firms some
protection in their entrepreneurial endeavors. We certainly hope, for example, that
important new inventions can rely on some level of protection as they are developed
into innovations and tested in the market place. This line of thinking implies that only
a few patents lead to important and successful innovations, while many patents are of
little value. The skewed distribution of patent values is well known (e.g. Schankerman
and Pakes, 1986; Gambardella et al., 2008). Some of these patents are associated with
smaller firms, hence the skewed patent value distribution is also reflected in the skewed
distribution of performance of smaller firms. Studies on new firms show that around
50% fail before 5 years and that only a tiny proportion grow to be large firms (Mata
and Portugal, 1994; Disney, Haskel and Heden, 2003). There is, therefore, a parallel
between the patent value distribution and the new firm performance distribution. This
can be referred to as the ‘1 in a 100’ issue where we might expect only 1 in a 100
patents or small firms to be valuable or successful - although, clearly, we do not have
1An exception is Buddelmeyer et al. (forthcoming) which looks at survival and intellectual property
for all Australian firms.
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any evidence on whether this ratio is appropriate. The ‘1 in a 100’ issue raises another
way of interpreting the question in the title. We could say that patents improve the
performance of small firms if they ensure that ‘1 in a 100’ achieve success (i.e., without
the patent system not even this one firm would survive). This discussion brings to our
attention another difficult issue when working with small firms: it is important to have
large samples, and preferably population data, so as to track all outcomes. Failing to
look at the entire population could easily lead to biased results depending on whether
the ‘1 in a 100’ firm is included or excluded.2
Faced with the various problems discussed above, this paper is based on a project
that has collated IP data on all UK registered firms over the period 2000 to date. The
data set also has complete data on all UK registered firms to construct control groups.
Specifically, for the purposes of this paper we focus attention on medium- and high-tech
industries as these are the ones most likely to face the choice to patent. Further, given
the huge attrition rate of new firms, we know that comparing a ten year old small firm,
with a two year old small firm, is ill advised. A ten year old firm has a much greater
chance of survival. It has already made a success of its initial innovation(s), which is
why firms are formed in the first place. The two year old firm is still attempting to
make a success of its innovation(s). This means if we are interested in assessing the
role of patents in the performance of small firms, it is best to compare firms of similar
age.
In order to do this, we take all new firms incorporated in 2000 in the UK (7,638)
in medium- and high-tech industries and calculate their average annual growth rate
between 2001 and 2005 (for the approximately 60% of start-ups that survive). Our
data allows us to identify the 303 start-ups that filed for a patent in 2000 or 2001.
In addition, we account explicitly for the possibility that firms were set up with the
purpose to capitalize on an invention made prior to the incorporation of the firm. This
is done by matching the names of the firms’ directors to patent names. We include
any directors’ patents in 1999, 2000 or 2001. We then ask whether the performance of
patentees is different from non-patentees.
The paper is structured as follows. The following section discusses the assumptions
necessary to allow us to identify any impact of patenting on performance. As will
2Of course, the term ‘biased’ depends on what objective the research has. For example, Hicks and
Hegde (2005) look only at small US firms with 15 or more patents in the 1996-2000 period that survived
until 2002. Such papers are interested only in the highly innovative firms and investigating aspects of
their behaviour, markets-for-technology in this case.
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become clear, even with complete population data there are a host of problems facing
the analysis. Section 3 describes the data set and Section 4 provides some descriptive
analysis. Section 5 discusses the results of our model. Section 6 contains a robustness
test. The last section concludes.
2 Identification
As is clear from the introduction, the problem in assessing whether patents affect the
performance of smaller firms is in identifying any patent effect. The ideal situation is to
have two groups of firms with inventions and with plans to turn these into new innova-
tions in the market. One group decides not to patent its inventions and the other does,
with this decision ideally being made randomly! The question is then whether the per-
formance of the patenting (treatment) group differs from the non-patenting (control)
group. If we had data from a randomized experiment, we could simply compare the
two distributions conditioning on possible systematic differences between patenting and
non-patenting firms, which would influence their performance even in the hypothetical
absence of any patents.3 This would be, in principle, sufficient to draw inference on
the estimated coefficient of patenting on firm growth. In reality we cannot set up such
a controlled experiment - firms choose whether to patent - and we are left with an
identification problem well known in the ‘treatment’ literature.
To summarize, there are three main difficulties in point-identifying the effect of a
firm’s decision to patent on its eventual performance. First, firms are heterogeneous.
If all firms had similar inventions and were identically endowed with regard to possible
determinants of their patenting decision, all firms would behave identically in choos-
ing whether to patent or not. But firms differ in many respects with regard to these
determinants. To the extent that heterogeneity is observable through, for example,
measures of firm size, the problem can be addressed as pointed out above. However,
it is highly unlikely that conditioning on these observable factors wipes out entirely
firm heterogeneity. Given the unobserved heterogeneity, the differences between the
outcome distributions of patenting and non-patenting firms may confound the effect of
patenting with unobserved differences in the population. Second, a firm’s decision to
patent and its performance are characterized by a simultaneous relationship: A firm’s
3Controlling for such differences, we avoid confounding differences in the outcome variable across
the two groups with a patent effect due to these systematic differences - this assumption is therefore
commonly referred to as ‘unconfoundedness’ in the treatment literature (Rosenbaum and Rubin, 1983).
Crucially, these variables have to be exogenous in the sense that they need to be unaffected by a firm’s
decision to patent in order to guarantee that the patent indicator is uncorrelated with omitted variables
affecting growth.
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decision to patent may depend on its performance and vice versa. Third, as is well-
known, a large share of firms exits the market every year. Omitting firms that have
failed from any performance analysis is likely to introduce selection bias in the estima-
tion.
Figure 1: Time line
t-1 t=0 t=1 t=5
Start
Patenting Decision Growth Process
In order to address these three issues we adopt the following identification strategy.
First, in order to minimize unobserved firm heterogeneity, we restrict our sample to a
cohort of high- and medium-tech firms incorporated in 2000. We assume that a firm is
incorporated with the objective to capitalize on an invention made before the date of
incorporation.4 In high- and medium-tech sectors, this assumption appears credible.
This assumption is not testable with our data, although we do estimate the model on
a narrower sub-set of industries as a robustness check.
Second, we tackle the simultaneity issue by considering the assumptions surround-
ing the time at which a patent is applied for. Once the invention is made, the founder
of the new company has the choice to apply for a patent. Hence, patents are applied
for either (1) shortly before a company is incorporated by one of its eventual direc-
tors or (2) by the firm itself shortly after it has been incorporated. Importantly, the
decision to patent the invention on which the company bases its commercial objec-
4Also note that while we attempt to reduce firm heterogeneity through sample homogeneity, one
could also argue that firms in our sample are subject only to uncertainty not heterogeneity at the
moment in which they decide to patent. According to Browning and Carro (2006), heterogeneity refers
to a situation when firms know their individual type is characterized by a number of factors determining
its actions. Hence, if firms hold identical beliefs about the patentability of their invention, there is no
heterogeneity affecting the observed patenting decisions.
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tive, arises before a firm starts competing in the market as shown in Figure 1. This
is an important timing assumption because it allows us to assume that the patenting
decision is exogenous with regard to firm performance. A related issue is whether
entrepreneurs, at the time of patenting, have good information on the expected value
of their invention and only patent those inventions with high expected values. Some
papers assume that the patent decision is made once the expected value of the related
innovation is known (Arora et al., 2008). In the current context of analyzing start-up
firms and their initial decisions to patent, this assumption of perfect foresight appears
too strong. Entrepreneurs are by nature optimistic and expect their projects to be
successful, yet there are large failure rates, something that is studied by the literature
on rates of return, bank finance and venture capital (Astebro, 2003). Further, even
if entrepreneurs do have some imperfect information on expected outcomes, it is not
clear that all valuable inventions are patented. There is evidence that other strategies,
such as secrecy and first mover advantage, may be used instead. From an econometric
point of view, firms may hold private information regarding the value of their invention;
we require only that this private information is uncorrelated with the patenting deci-
sion conditional on a vector observed firm characteristics entering the growth equation.5
Third, the issue of selection bias is addressed through a standard Heckman (1976,
1979) selection model. Our objective is to estimate the growth equation
4y∗i = βxXi + νi (1)
where 4y∗i denotes firm i’s growth rate, Xi are exogenous covariates including the
patent variable. We assume that the unknown error νi is normally distributed. The
problem with (1) is that y∗i is observed only if a firm does not exit during the period
analyzed. If we denote a firm’s decision to stay in the market or exit as si ∈ (0, 1),
we observe 4y∗i if and only if si = 1; we denote the observed growth rate as 4yi.
Therefore, we can rewrite (1) as
4yi = βxXi + νi iff si = 1 (2)
Selection bias arises if Cov(Xi, νi|si = 1) 6= 0, i.e., if in the observed sample of
surviving firms’ covariates are no longer exogenous. To see this problem more clearly,
we parameterize a firm’s decision to stay in the market as
5This is again the standard unconfoundedness or ‘selection on observables’ assumption in the treat-
ment literature.
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si =
1 if βzZi + εi ≥ 00 otherwise (3)
where Zi denotes firm characteristics influencing a firm’s decision to stay in the
market. Importantly, to ensure identification of βx in (1), Zi must contain at least one
variable excluded from Xi.6 Using (3), we can rewrite (1) as
E(4yi|Xi, si = 1) = βxXi + E(νi|Xi, si = 1) = βxXi + E(νi|εi) (4)
We therefore encounter selection bias if Cov(νi, εi) 6= 0, which is the case if there are
unobservables affecting growth as well as firm survival. In addition, if the variables in
the growth equation are correlated with the variables in the selection equation, provided
that Cov(νi, εi) 6= 0, Xi is no longer exogenous in (1). Heckman (1976) proposed
a well-known solution based on the assumption that νi and εi are jointly normally
distributed. Then equation (3) can be used to estimate a correction term which is used
as an additional regressor in (4) proxying E(νi|εi). If the model is correctly specified,
the most efficient estimators are obtained from estimating equations (4) and (3) jointly
by Full Information Maximum Likelihood (FIML). While this method has received an
astonishing amount of attention in the literature, it is important to stress that using
the Heckman approach, equation (4) is estimated including a selection correction term
as E(4y|x, s = 1) = xβ + σρ φ(·)Φ(·) , where s = 1 denotes survivor firms, φ(·)Φ(·) the inverse
Mills Ratio estimated based on (3), and ρ the correlation between the errors of the
selection and growth equations and σ is the standard deviation of the error in the
growth equation. It is clear from this expression that E(4y|x, s = 1) is the sum of
a linear function xβ and the nonlinear Inverse Mills ratio. The nonlinear form of the
Inverse Mills ratio is based crucially on the normal-linear assumptions of the model and
any deviations from it would affect how E(4y|x, s = 1) changes as a consequence of
marginal changes in x making it a tenuous approach to addressing selection (Manski,
2007).7
3 Data
The data used for the analysis comes from the Oxford Firm Level IP database (OFLIP).
The database draws on the Financial Analysis Made Easy (FAME) data that covers
6Otherwise variation in the Inverse Mills ratio is not independent from variation in Xi preventing
identification of β.
7Das et al. (2003) and Newey (2007) have proposed alternative, non-parametric estimators for
correcting for selection. These methods have attractive characteristics that may make them well suited
for analysis of patenting, but work in this direction is left for a future paper.
7
the entire population of registered UK firms (FAME downloads data from Companies
House records).8 OFLIP contains additional information on the IP activity of firms
in the form of patents and trademarks. OFLIP has been constructed by matching the
FAME database and a number of firm-level IP data sets.9
The FAME database is a commercial database provided by Bureau van Dijk.10 To
construct the data set, the December 2006 edition of FAME has been used. The finan-
cial data was updated using the May 2008 edition of FAME. FAME covers around 2.04
million active firms. For all of these firms, basic information, such as name, registered
address, firm type, and industry code are available. Availability of financial informa-
tion varies substantially across firms. The smallest firms are legally required to submit
only very basic balance sheet information such as shareholders’ funds and total assets,
which imposes severe constraints on the analysis of small firms. Importantly, the FAME
database also lists around 0.9 million so called ‘inactive’ firms. These inactive firms
are those that have exited the market and belong to one of the following categories:
dissolved, liquidated, entered receivership or declared non-trading. Also, FAME gives
exact dates for market entry in the form of a firm’s incorporation date, which allows
us to identify our cohort of firms set up in 2000. To determine date of exit we use the
date that the last set of accounts were filed.
The intellectual property (IP) data used for the construction of OFLIP database
comes from three different sources: the UK IP Office, Marquesa Ltd. and the Euro-
pean Patent Office (EPO) ESPACE Bulletin. Data on UK patent publications were
supplied by the UK IP Office. Marquesa Ltd supplied data on UK trademark publica-
tions and Community (OHIM) marks registered. Data on EPO publications by British
entities was downloaded from ESPACE Bulletin DVD 2006/001. The analysis uses the
application date of UK and EPO patents, and trademarks.11 This said, only patents
that are published are in the public domain. Hence, it is not possible to observe those
patents that were withdrawn before their publication. Given the usual 18 months pe-
riod between application and publication date, we should observe all patents that made
it to the publication stage. Note that for this paper, we have complemented OFLIP
8In the remainder of this work we use firms to mean registered firms. Hence firm refers to the legal
entity that organizes production, in contrast to census-type data that uses the plant or production
unit.
9For details on the matching process and further details on the database see Rogers, Helmers, and
Greenhalgh (2007).
10http://www.bvdep.com/en/FAME.html
11It is possible that small UK firms file for patents at the US PTO, which we do not have data for;
however, our view is that the numbers involved are likely to be low. We do have patents filed at WIPO
under the PCT if they have subsequently been published in the UK or at the EPO.
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with patents and trademarks applied by firms’ directors. FAME indicates the names
and addresses of firms’ directors, which enabled us to match them to the patent and
trademark data sets. In summary, we create an indicator variable that takes the value
of one if a firm applied for a patent either (a) itself in 2000 or 2001 or (b) through
one of its directors in 1999, 2000, or 2001.12 Similarly, for trademarks, the indicator
variable assumes the value of one if a firm applied for a trademark (a) itself in 2000 or
2001 or (b) through one of its directors in 2000 or 2001.
The objective is to analyze the effect of patenting on start-up firms, which should
be regarded to an overwhelming extent as small firms, at least during their initial years
of existence. To ensure this we only include firms with less than £2.4 million in total
assets in its first set of accounts (the EU definition of a small firm). In our data, about
40% of firms fail during the 2000-2005 period and, of the surviving ones, only 3.21%
grow from the micro category into the small and medium size (SME) category and
0.22% into the large firm category.13 The medium- and high-tech sectors in the sample
are listed in Table 1.14 The use of assets as our size and growth measure is due to
reporting requirements in the UK. All firms must report assets to Companies House,
whose data is in turn imported into FAME. Using turnover data would create a severe
sample selection bias as only larger firms are required to report turnover.
The information on firms’ exit decisions allows us to distinguish firms that do not
report asset data from firms that have exited. This is a distinct advantage of our data.15
However, here is a potential problem since 13% of the firms in the sample do not report
asset data either in 2001 or 2005, or both, despite the fact that they are still operating
at the end of 2005. This represents a problem of missing data. Instead of omitting the
observations for which we do not observe growth rates, we impute missing asset data
to obtain full coverage of growth rates for the sample of surviving firms. Crucially, the
ability to impute missing values and to obtain consistent estimators of any model using
the data rests on the ‘missing at random’ assumption. In our case, because the only
12If a director applied for a patent in 1999, before officially assuming his post as a director of the
start-up, this implies that the start-up was launched to market the patent application. This does, of
course, assume that the director’s patent is related to the start-up’s activities. This may not be true if
the director had other business or research interests, but we adjudge this to be unlikely in the majority
of cases.
13A micro firm has total assets less that £1.3 million, an SME has assets less than £28 million, and
a large firm above this. These are based on EU definitions.
14We employ the OECD definition of medium- and high-tech sectors adding the SIC-2003 sectors
722 and 731. Section 6 analyses whether restricting our sample to the OECD definition significantly
affects our results.
15We have also attempted to discover which small firms were taken over in the period. However, the
merger and acquisition databases provided by Bureau van Dijk and Thomson have very little data on
small firms.
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Table 1: Industries in the Sample
Description SIC-3
Manufacture of Chemicals and Chemical Products 24
Manufacture of Machinery and Equipment 29
Manufacture of Office Machinery and Computers 300
Manufacture of Electrical Machinery and Apparatus 31
Manufacture of Radio, Television and Communication Equipment 32
Manufacture of Medical, Precision and Optical Instruments 33
Manufacture of Motor Vehicles, Trailers and Semi-Trailers 34
Manufacture of Railway and Tramway Locomotives 352
Manufacture of Aircraft and Spacecraft 353
Software Consultancy and Supply 722
R&D on Natural Science and Engineering 731
missing variable is the dependent variable, the ‘missing at random’ assumption is equiv-
alent to the ‘selection on observables’ assumption, i.e., P (m = 1|y, x) = P (m = 1|x),
where m is an indicator variable equal to one if the outcome variable is missing and
zero otherwise.16
The sample contains 303 patentees. Of these, 83% survived to 2005, which is much
higher than the 60% for the entire sample. Of the 303 patentees, around 70% of them
applied for a UK patent and 58% applied for a EPO patent (28% of them applied
for both UK and EPO patents). Firms’ directors applied for 36 UK patents, 47 EPO
patents and 32 UK trademarks.
4 Descriptive Analysis
In this section, we summarize the data through their unconditional distributions and
relate these distributions to each other. Table 2 shows unconditional distributions of
growth rates across firms. Growth rates are calculated as the difference between the
log of a firm’s total assets in 2005 and 2001 (divided by four to express annual growth).
A feature of these tables is a ‘hollowing-out’ effect, i.e., that IP-active firms are more
concentrated either in the low growth or the high growth quartile. Table 2 provides
first strong evidence that the distributions of IP-active and IP-inactive firms differ. In
order to verify this for the entire distributions, Figure 2 plots the unconditional proba-
bility density functions of growth rates of patenting against non-patenting firms. The
16Note that this is weaker an assumption than ‘missing completely at random’, which assumes that
m is independent of (y, x).
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distribution of patenting firms appears to be characterized by a shape shift vis-a`-vis
the non-patenting firm growth distribution, while the location of the distributions ap-
pears similar. The analysis will investigate whether both distributions, summarized
by their means, are statistically significantly different from each other. The important
assumption made in such an analysis is that both distributions are comparable once we
condition them on the set of variables Xi in combination with our timing assumption
and homogeneity of the sample analyzed.
Tables 3 and 4 provide summary statistics for the sample of surviving firms. Table
3 contains the entire sample of survivors used in the growth regressions, whereas Ta-
ble 4 splits the sample into patenting and non-patenting firms. It provides additional
evidence by showing summary statistics for patenting and non-patenting firms which
applied for a trade mark. The university variable measures the minimum geographical
distance from a firm’s location to the nearest university. The variable is computed
by matching firms’ postcodes and universities’ postcodes with Code-Point data pro-
vided by Edina Digimap.17 Given the grid points for firm i and university j, bilateral
geographical distances are calculated.18 The subsidiary variable is a binary variable
indicating whether a firm is part of a holding company (FAME contains information on
the ownership structure of firms). However, ownership data are only available for the
last set of financial accounts of any firm (e.g. 2005 for survivors), hence the variable
does not capture possible changes in a firm’s status through time.
5 Results
The first table of results (Table 5) shows a set of OLS regressions for both the basic
data and also the imputed data. The dependent variable is the annual average growth
rate of assets over the period 2001 to 2005. The variable patent is a dummy variable for
whether the firm had a patent, either UK or EPO. The binary variables UK patent and
EPO patent simply break this dummy variable into its two components. The results on
all the patent variables are significant and positive, with the imputed sample showing
higher values for patent and EPO patent. For reference, the 95% confidence interval
for the 0.147 coefficient on patent in regression (1) is between 0.09 and 0.20. The re-
sults also indicate that trade marking (in 2000 and 2001) is statistically significantly
associated with subsequent asset growth. The number of directors also has a positive
association with a firm’s growth rate. In contrast, greater distance from a university
and larger initial size have negative associations with firms’ growth rates.
17http://digimap.edina.ac.uk/main/index.jsp
18Distance =
√| northingi − northingj |2 + | eastingi − eastingj |2.
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As discussed in Section 2, the OLS results may suffer from sample selection bias.
Table 6 shows the standard Heckman model (using FIML) with the survival model
results in the lower part of the table and the growth model results in the upper part of
the table. The survival model also includes a number of industry and regional variables
which are intended to capture entry and exit costs and the ability to refinance (see
Appendix A). The survival model indicates that IP activity is positively associated
with survival. Specifically, the coefficients on the patent dummies are all positive and
significant, and their magnitudes imply substantial increases in survival probability.
Moreover, a Lagrange Multiplier test for ρ, capturing correlation between unobserv-
ables affecting survival and unobservables affecting firm growth, being equal to zero is
rejected at the 1% level for all four specifications (1) - (4). Hence, the estimates for ρ
indicate statistically significant negative correlation between unobservables suggesting
the presence of selection bias in the OLS results.
The upper half of the table shows that the coefficient estimates on the patent
dummy in the growth model are reduced by more than half. This suggests that failing
to control for selection creates a substantial upward bias in the patent coefficient due
to only using surviving firms. The results are broadly consistent whether we use the
sample with or without the imputed values. The growth model results also show that
the coefficients on the UK or EPO dummy variables are always positive but only sig-
nificant for the EPO dummy in regression (4).
The magnitude of the coefficient on the patent dummy in the growth models (1)
and (3) in Table 6 is 0.06 and 0.08 respectively. This implies that when we control for
selection bias, a patentee is associated with a 6% to 8% higher growth rate per annum.
This is just below the 95% confidence interval from the OLS results in regression (1)
reported in Table 5.
A further issue concerns whether any potential growth impact of patenting depends
on the influence of firm size. One hypothesis might be that patenting can only benefit
firms of a certain size since only these have the necessary resources to pursue and defend
their intellectual property. Even though all the firms here are small, the initial size in
2001 still varies up to 2.4 million pounds. One way to investigate this is to create
an interaction term between the patent dummy and asset size in 2001, and enter this
as an additional explanatory variable (in both selection and growth model). Table 7
shows the coefficients for patent and interaction terms from a Heckman model (other
coefficients are omitted since they are very similar to those reported in Table 6. As
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can be seen, the results indicate that the interaction term is negative but statistically
insignificant in most cases. The exception to this is for the patent dummy in the non-
imputed sample, and the results for EPO patents in both samples. The significant,
negative coefficient on the interaction between EPO dummy and a firm’s initial assets
is consistent with smaller patentees having higher growth.
6 Robustness
As discussed earlier, constraining the sample to high- and medium-tech industries is
important to limit heterogeneity. However, even within these industries there is vari-
ation across start-ups. To investigate the implication of this, industries 722 and 731
were dropped. Software Consultancy and Supply (722) has the most start-ups and
some of these may be related to service-based ideas that have less inventive content;
R&D on National Science and Engineering (731) is a specialized classification and may,
therefore, introduce undesired heterogeneity in firms’ propensity to patent. Removing
these two industries reduces the sample size for the non-imputed sample in the selec-
tion stage from 7,038 to 1,407 and in the growth regression from 3,981 to 1,000. The
results from reproducing Table 6 with the smaller sample confirm the general pattern of
results discussed above. For the patent variables the coefficients are generally higher.
In particular, the coefficient on the patent variable in Table 6 for the non-imputed
sample was 0.08, whereas in Table 8, the coefficients is three times as large. Also the
coefficients of the binary variables UK patent and EPO patent in column (4) of Table
8 are both statistically significant and much larger in magnitude than the coefficients
reported in column (4) of Table 6.
7 Conclusion
This paper has used new data on the IP activity of all UK firms in an attempt to assess
the impact of patenting on start-up firms. The paper analyzes the growth rate of assets
(2001 to 2005) of medium- and high-tech start-ups incorporated in 2000. Growth of
assets are used since this is the only measure of firm size that must be reported by
small firms. Patenting is measured by a patent application in 1999 to 2001 (which was
subsequently published). Importantly, we take account of the patenting activity of the
firm’s directors (in 1999 to 2001) to capture the fact that firms are often incorporated
to exploit inventions of specific scientists or entrepreneurs. Trying to assess any impact
of patenting on performance faces a range of difficulties. There is huge heterogeneity in
start-up firms with many firms being unlikely to patent, hence our focus on medium-
and high-tech start-ups. The paper assumes that all such start-ups have a new idea
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that could, in principle, be patented. Further, we assume that the decision to patent is
made in 1999 to 2001, which is prior to full engagement in market activity. This reduces
concerns over simultaneity (i.e., that high growth increases chance of patenting).
Any identification of the impact of patenting on firm performance relies on the
assumption that all start-ups (in their first year of existence) have similar expecta-
tions regarding their future growth rate (i.e., it is not only high growth potential firms
that patent). This assumption is based on two observations. First, entrepreneurs in
medium- and high-tech industries tend to be optimistic and expect their projects to be
highly successful. Second, patents are not viewed by entrepreneurs as the only method
of exploiting good ideas.
The low survival rate of start-up firms means that it is particularly important to
control for sample selection. The data set used here is rich enough to allow us to do this
as it records the exit of any firm and we can distinguish this from simply missing values.
Using a standard Heckman selection model we find that sample selection appears to be
important. In estimating the selection model we also find that patenting has a strong
positive association with survival. The Heckman model finds that the association be-
tween patenting and subsequent asset growth is between 6% and 8% (i.e., a start-up
that patents in 1999-2001 has a 6% to 8% higher annual growth rate between 2001
and 2005 than a firm that does not patent). The 95% confidence intervals for these
point estimates are between 0% and 12.3% and 2.2% and 13.7% respectively. There is
also some evidence that this association is higher for smaller firms. As is well known,
the Heckman model results are sensitive to the joint normality assumptions it relies
on. The OLS results ignoring sample selection suggest a patent to be associated with
between 9% and 20% higher subsequent annual growth.
The paper has not been able to investigate reasons why such an association might
exist. Clearly, our assumptions regarding the timing and nature of the decision to
patent are critical to any interpretation. Even if there is some underlying causality
between patents and performance, it is not clear what might be driving this. Start-up
firms could be using patents as a signal to capital markets, which then allows them
to borrow more. Having more finance available could then allow higher growth (in
fact, borrowing money to buy assets would have a direct impact on our asset growth
measure). Alternatively, start-up firms might find having a patent(s) helps in negoti-
ations with customers or suppliers. Finally, patents may have their traditional benefit
of providing some degree of market power.
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A Appendix: Description of variables used in selection
equation
The survival indicator of the selection equation is constructed using the information
of ‘inactive’ firms available in FAME. Inactive firms are those that have exited the
market and belong to one of the following categories: dissolved, liquidated, entered
receivership or declared non-trading. This information on inactive firms allows us to
identify all firms entering and exiting the market throughout the five-year period anal-
ysed.
The minimum efficiency scale is calculated as the ratio of average first-year firm
size to average firm size within the SIC-3 industry.
Capital intensity is computed as the ratio of the amount of firms’ assets and labor
within each SIC-3 industry.
The 4-firm concentration ratio is computed as the share in total assets of the
four largest firms within a SIC-3 industry.
Unemployed rates are measured as the ratio of unemployed over all economically
active persons by county and unitary authority. For Northern Ireland, we used the
unemployment rate at the country level. The data for the UK comes from the UK
Office for National Statistics’ Labour Force Survey (LFS) where we calculated annual
averages from the quarterly data available.
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Figure 2: Density Distributions of Patenting vs. Non-Patenting Firms
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Table 3: Summary Statistics: Growth Regression
Variable Mean Median 25% 75% St. Dev. Observations
(1) (2) (3) (4) (5) (6)
Growth Assets 2001-2005 0.095 0.029 -0.097 0.262 0.428 3981
UK Patent 0.044 0 0 0 0.204 3981
EPO Patent 0.038 0 0 0 0.192 3981
Patent 0.063 0 0 0 0.244 3981
Trademark 0.082 0 0 0 0.274 3981
ln Dist. University 1.768 1.871 0.986 2.501 0.909 3981
ln Directors 1.106 1.098 0.693 1.386 0.429 3981
Subsidiary 0.069 0 0 0 0.253 3981
ln Assets in 2001 3.235 3.148 1.658 4.363 2.392 3981
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Table 5: Results: OLS
Covariate Asset Growth 2001-2005
Imputed Values
(1) (2) (3) (4)
Patent 0.147** 0.167**
(0.033) (0.026)
UK Patent 0.101* 0.106**
(0.043) (0.033)
EPO Patent 0.119** 0.143**
(0.044) (0.036)
Trade Mark 0.122** 0.120** 0.122** 0.120**
(0.028) (0.028) (0.023) (0.023)
ln Directors 0.110** 0.109** 0.133** 0.131**
(0.019) (0.019) (0.015) (0.016)
ln Dist. University -0.017* -0.017* -0.018** -0.018**
(0.007) (0.007) (0.006) (0.007)
ln Assets in 2001 -0.074** -0.075** -0.088** -0.089**
(0.004) (0.004) (0.003) (0.003)
Subsidiary 0.027 0.026 0.002 0.001
(0.034) (0.033) (0.024) (0.024)
R2 0.151 0.151 0.201 0.201
No. Obs. 3981 3981 4407 4407
Notes:
1. Robust Standard Errors in parentheses.
2. + indicates significance at 10%; * at 5%; ** at 1%.
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Table 6: Results: Heckman Selection Correction (ML Estimates)
Covariate Asset Growth 2001-2005
Imputed Values
(1) (2) (3) (4)
Patent 0.063* 0.080**
(0.030) (0.029)
UK Patent 0.048 0.049
(0.037) (0.036)
EPO Patent 0.062 0.084*
(0.040) (0.039)
Trade Mark 0.056* 0.052* 0.055* 0.052*
(0.027) (0.027) (0.026) (0.026)
ln Directors 0.082** 0.080** 0.103** 0.101**
(0.017) (0.017) (0.016) (0.016)
ln Dist. University -.025** -0.026** -0.026** -0.027**
(0.007) (0.007) (0.007) (0.007)
ln Assets in 2001 -0.076** -0.076** -0.090** -0.091**
(0.003) (0.003) (0.003) (0.003)
Subsidiary 0.026 0.025 0.003 0.002
(0.025) (0.025) (0.024) (0.024)
No. Obs. 3981 3981 4407 4407
Covariate Survival 2001-2005
Imputed Values
(1) (2) (3) (4)
Patent 0.918** 0.898**
(0.120) (0.118)
UK Patent 0.631** 0.624**
(0.147) (0.144)
EPO Patent 0.815** 0.799**
(0.172) (0.169)
Trade Mark 0.742** 0.743** 0.707** 0.707**
(0.088) (0.088) (0.086) (0.086)
ln Directors 0.211** 0.211** 0.217** 0.218**
(0.039) (0.040) (0.039) (0.039)
CR-4 1.014** 1.023** 1.009** 1.019**
(0.115) (0.115) (0.111) (0.111)
MES 18.396+ 18.374+ 17.125+ 17.111+
(10.080) (10.098) (9.928) (9.946)
Capital Intensity 0.0002** 0.0002* 0.0002** 0.0002**
(0.000) (0.000) (0.000) (0.000)
Unemployment -5.072** -5.042** -4.481** -4.458
(0.796) (0.795) (0.772) (0.770)
ρ -0.511 -0.515 -0.552 -0.557
(0.49) (0.478) (0.045) (0.044)
LR (ρ = 0) 38.16 40.36 44.91 47.75
p=0.000 p=0.000 p=0.000 p=0.000
No. Obs. 7038 7038 7464 7464
Notes:
+ indicates significance at 10%; * at 5%; ** at 1%.
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Table 7: Results for interactions: Heckman Selection Correction (ML Estimates)
Selected covariates Asset Growth 2001-2005
Imputed Values
(1) (2) (3) (4)
Patent 0.124** 0.110*
(0.048) (0.046)
Patent x ln(asset) -0.014+ -0.007
(0.008) (0.008)
UK patent 0.056 0.045
(0.059) (0.057)
UK patent x ln(asset) 0.000 0.002
(0.011) (0.011)
EPO patent 0.195** 0.180**
(0.070) (0.067)
EPO patent x ln(asset) -0.027* -0.020+
(0.012) (0.012)
No. Obs. 3981 3981 4407 4407
Notes:
1. + indicates significance at 10%; * at 5%; ** at 1%.
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Table 8: Robustness Test Results (without SIC-3 722 and 731): OLS and Heckman
Selection Correction (ML Estimates)
Covariate Asset Growth 2001-2005
(1) (2) (3) (4)
Patent 0.154** 0.241**
(0.051) (0.052)
UK Patent 0.117+ 0.175**
(0.063) (0.064)
EPO Patent 0.103 0.165*
(0.073) (0.076)
Trade Mark 0.068+ 0.065 0.141** 0.137**
(0.041) (0.041) (0.050) (0.041)
ln Directors 0.083* 0.080+ 0.109** 0.105**
(0.041) (0.042) (0.038) (0.038)
ln Dist. University -0.018 -0.017 -0.005 -0.004
(0.015) (0.015) (0.015) (0.015)
ln Assets in 2001 -0.069** -0.069** -0.060** -0.060**
(0.006) (0.006) (0.005) (0.005)
Subsidiary -0.042 -0.045 -0.092* -0.093*
(0.057) (0.057) (0.045) (0.045)
R2 0.188 0.188
No. Obs. 1000 1000 1000 1000
Covariate Survival 2001-2005
(3) (4)
Patent 0.608**
(0.159)
UK Patent 0.371*
(0.188)
EPO Patent 0.585*
(0.262)
Trade Mark 0.402** 0.391**
(0.142) (0.143)
ln Directors 0.241** 0.227**
(0.085) (0.086)
CR-4 0.003 0.003
(0.194) (0.194)
MES 11.123 11.127
(8.887) (8.897)
Capital Intensity 0.000 0.000
(0.000) (0.000)
Unemployment -3.804* -3.771*
(1.575) (1.574)
ρ 0.797 0.798
(0.034) (0.034)
LR (ρ = 0) 25.76 25.59
p=0.000 p=0.000
No. Obs. 1407 1407
Notes:
1. Robust Standard Errors in parentheses in columns (1) and (2).
2. + indicates significance at 10%; * at 5%; ** at 1%.
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